BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 9416454)

  • 1. Vigabatrin in refractory childhood epilepsy. The Brazilian Multicenter Study.
    Gherpelli JL; Guerreiro MM; da Costa JC; Rotta NT; Manreza ML; Reed UC; Diament A; Silva EA; Guerreiro CA; Nunes ML; Palmini A; Vega-Gutiérrez L; Vizioli J; Pedroso F; Chisté MA
    Epilepsy Res; 1997 Dec; 29(1):1-6. PubMed ID: 9416454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vigabatrin as add-on therapy in children and adolescents with refractory epilepsy: an open trial.
    Coppola G; Terraciano AM; Pascotto A
    Brain Dev; 1997 Nov; 19(7):459-63. PubMed ID: 9408591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vigabatrin in childhood epilepsy: comparable efficacy for generalized and partial seizures.
    Sheth RD; Buckley D; Penney S; Hobbs GR
    Clin Neuropharmacol; 1996 Aug; 19(4):297-304. PubMed ID: 8828992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New drugs in the treatment of childhood epilepsy: vigabatrin (study of 61 subjects)].
    Raucci U; Spalice A; Basile LA; Guardalà C; Nasta L; Terenzi S; Iannetti P
    Pediatr Med Chir; 1994; 16(6):575-8. PubMed ID: 7708543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of lamotrigine, vigabatrin and gabapentin as add-on therapy in intractable epilepsy of childhood.
    McDonald DG; Najam Y; Keegan MB; Whooley M; Madden D; McMenamin JB
    Seizure; 2005 Mar; 14(2):112-6. PubMed ID: 15694564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Vigabatrin and lamotrigin: experiences with 2 new anticonvulsants in the Swiss epilepsy clinic].
    Vogt H; Krämer G
    Schweiz Med Wochenschr; 1995 Jan; 125(4):125-32. PubMed ID: 7878401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vigabatrin use in 72 patients with drug-resistant epilepsy.
    Buchanan N
    Seizure; 1994 Sep; 3(3):191-6. PubMed ID: 8000713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vigabatrin in the management of generalized seizures in children.
    Appleton RE
    Seizure; 1995 Mar; 4(1):45-8. PubMed ID: 7788106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vigabatrin in unsatisfactory controlled epilepsies. Swiss Vigabatrin Study Group.
    Russ W
    Schweiz Arch Neurol Psychiatr (1985); 1995; 146(2):55-9. PubMed ID: 7569836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-response study of vigabatrin in children with refractory epilepsy.
    Herranz JL; Arteaga R; Farr IN; Valdizan E; Beaumont D; Armijo JA
    J Child Neurol; 1991; Suppl 2():S45-51. PubMed ID: 1940124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A survey comparing lamotrigine and vigabatrin in everyday clinical practice.
    Schapel G; Chadwick D
    Seizure; 1996 Dec; 5(4):267-70. PubMed ID: 8952011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of vigabatrin and lamotrigine in treatment of childhood epileptic syndromes.
    Bélanger S; Coulombe G; Carmant L
    Epilepsia; 1998 Aug; 39(8):878-83. PubMed ID: 9701380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and tolerability of vigabatrin in children with refractory partial seizures: a single-blind dose-increasing study.
    Dalla Bernardina B; Fontana E; Vigevano F; Fusco L; Torelli D; Galeone D; Buti D; Cianchetti C; Gnanasakthy A; Iudice A
    Epilepsia; 1995 Jul; 36(7):687-91. PubMed ID: 7555986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vigabatrin as first add-on treatment in carbamazepine-resistant epilepsy patients.
    Murri L; Iudice A
    Acta Neurol Scand Suppl; 1995; 162():40-2. PubMed ID: 7495189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicentre clinical evaluation of vigabatrin (Sabril) in mild to moderate partial epilepsies. French Neurologists Sabril Study Group.
    Arzimanoglou AA; Dumas C; Ghirardi L
    Seizure; 1997 Jun; 6(3):225-31. PubMed ID: 9203252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing the indication of vigabatrin in children with refractory epilepsy.
    Lortie A; Chiron C; Dumas C; Mumford JP; Dulac O
    J Child Neurol; 1997 Jun; 12(4):253-9. PubMed ID: 9203067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vigabatrin treatment in children.
    Fois A; Buoni S; Di Bartolo RM; Di Marco V; Mostardini R
    Childs Nerv Syst; 1994 May; 10(4):244-8. PubMed ID: 7923235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vigabatrin in pediatric epilepsy--an open study.
    Uldall P; Alving J; Gram L; Beck S
    J Child Neurol; 1991; Suppl 2():S38-44. PubMed ID: 1940123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective study of first-line vigabatrin monotherapy in childhood partial epilepsies.
    Gobbi G; Pini A; Bertani G; Menegati E; Tiberti A; Valseriati D; Besana D; Rasmini P; Guerrini R; Belmonte A; Veggiotti P; Resi C; Lanzi G; Capovilla G; Galeone D; Milani S
    Epilepsy Res; 1999 May; 35(1):29-37. PubMed ID: 10232792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study.
    Callenbach PM; Arts WF; ten Houten R; Augustijn P; Gunning WB; Peeters EA; Weber AM; Stroink H; Geerts Y; Geerts AT; Brouwer OF
    Eur J Paediatr Neurol; 2008 Jul; 12(4):321-7. PubMed ID: 17950011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.